HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 11/21/2012 -- Sarepta Therapeutics (NASDAQ:SRPT) was also up, increasing 6.67 percent to $28.80 after a company officer was officially awarded a patent this morning. Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., is a biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of both rare and infectious diseases.
Find out where SRPT is headed next Find out here
Amarin Corporation plc (ADR) (NASDAQ:AMRN) closed at the price of $10.62 whereas its previous closing was recorded at $10.84. The stock traded within the day range of $5.99–15.96 and 52week range remained in between $5.99- $15.96. The stock has the total volume of 4.28 million shares; its average volume was 4.87 million shares for the last 3 months as compared to the market capitalization of $1.59 billion. Amarin Corporation plc (ADR) has the total of 149.77 million outstanding shares as compared to 149.51 million shares that were floated in the market.
Can AMRN Extend Rally? Find Out Here
Salesforce.com, inc. (NYES:CRM) disclosed a third-quarter loss of $1.55 per share, wider than the year-ago per-share loss of $0.03. Excluding items, the firm banked 33 cents per share, a penny above expectations. Revenue totaled $788.4 million, north of the estimated $776.6 million. For the fourth quarter, CRM expects per-share results between 38 and 40 cents per share.
Can CRM Move Up Further? If Yes, How far It can Go? Find Out Here
Sequenom, Inc. (NASDAQ:SQNM) reported ($0.26) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.23) by $0.03. The company had revenue of $22.90 million for the quarter, compared to the consensus estimate of $22.91 million. During the same quarter in 2011, the company posted ($0.19) earnings per share. The company’s quarterly revenue was up 68.4% on a year-over-year basis. On average, analysts predict that Sequenom will post $-0.98 earnings per share for the current fiscal year.
How Should Investors Trade SQNM Now? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)